179 related articles for article (PubMed ID: 3680520)
1. Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa.
Shimamoto C; Weinstein WM; Boland CR
J Clin Invest; 1987 Dec; 80(6):1670-8. PubMed ID: 3680520
[TBL] [Abstract][Full Text] [Related]
2. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
3. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.
Hamilton SR; Smith RR
Am J Clin Pathol; 1987 Mar; 87(3):301-12. PubMed ID: 3825997
[TBL] [Abstract][Full Text] [Related]
4. Blood group-related antigen expression in normal and metaplastic human upper gastrointestinal mucosa.
Davidson JS; Triadafilopoulos G
Gastroenterology; 1992 Nov; 103(5):1552-61. PubMed ID: 1426874
[TBL] [Abstract][Full Text] [Related]
5. Structural alterations of the mucosa stroma in the Barrett's esophagus metaplasia-dysplasia-adenocarcinoma sequence.
Bobryshev YV; Killingsworth MC; Lord RV
J Gastroenterol Hepatol; 2012 Sep; 27(9):1498-504. PubMed ID: 22591183
[TBL] [Abstract][Full Text] [Related]
6. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in columnar-lined Barrett's esophagus. Analysis of 13 esophagectomies.
Saubier EC; Gouillat C; Samaniego C; Guillaud M; Moulinier B
Am J Surg; 1985 Sep; 150(3):365-9. PubMed ID: 4037198
[TBL] [Abstract][Full Text] [Related]
8. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
9. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Griffiths EA; Pritchard SA; McGrath SM; Valentine HR; Price PM; Welch IM; West CM
Br J Cancer; 2007 May; 96(9):1377-83. PubMed ID: 17437013
[TBL] [Abstract][Full Text] [Related]
10. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type.
Offner FA; Lewin KJ; Weinstein WM
Hum Pathol; 1996 Sep; 27(9):885-9. PubMed ID: 8816881
[TBL] [Abstract][Full Text] [Related]
11. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
13. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
Lord RV; Wickramasinghe K; Johansson JJ; Demeester SR; Brabender J; Demeester TR
Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
Sharma P
Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
16. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice.
Alikhan M; Rex D; Khan A; Rahmani E; Cummings O; Ulbright TM
Gastrointest Endosc; 1999 Jul; 50(1):23-6. PubMed ID: 10385717
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
[TBL] [Abstract][Full Text] [Related]
18. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
20. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
